Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Terminated 2Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 29Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Squamous Cell Carcinoma 7Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ovarian Neoplasms 4Biliary Tract Neoplasms 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Pancreatic Ductal 3Vaccinia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms by Site 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Ureteral Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1

Interventions

Oxaliplatin 10pembrolizumab 8Fluorouracil 8Leucovorin 7Paclitaxel 5Gemcitabine 5Docetaxel 5Capecitabine 5Cyclophosphamide 4Blood Specimen Collection 4zolbetuximab 3fludarabine 3darolutamide 3cemiplimab 3Trastuzumab 3Taxes 3Ramucirumab 3Radiotherapy 3Radiosurgery 3Irinotecan 3trastuzumab deruxtecan 2enzalutamide 2durvalumab 2Standard of Care 2Nivolumab 2Folfox protocol 2Dexamethasone 2Cisplatin 2130-nm albumin-bound paclitaxel 2tucatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT07259317 2026-04-23

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Corcept Therapeutics

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Ductal

NCT05241249 2025-06-05

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Columbia University

Phase 2 Recruiting
37 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡